1. Search Result
Search Result
Results for "

human PR

" in MedChemExpress (MCE) Product Catalog:

24

Inhibitors & Agonists

3

Peptides

3

Inhibitory Antibodies

17

Recombinant Proteins

5

Antibodies

7

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-10964
    Vadimezan
    70+ Cited Publications

    DMXAA; ASA-404

    STING IFNAR Influenza Virus Infection Cancer
    Vadimezan (DMXAA), the tumor vascular disrupting agent (tumor-VDA), is a murine agonist of the stimulator of interferon genes (STING) and also a potent inducer of type I IFNs and other cytokines. Vadimezan is unable to activate human STING. Vadimezan has anti-influenza virus H1N1-PR8 activities.
    Vadimezan
  • HY-176533

    LPL Receptor Neurological Disease
    S1PR5-IN-1 (Compound 7a) is a highly selective S1PR5 antagonist and orally bioavailable inhibitor with a human S1PR5 IC50 of 85.4 nM and human S1PR5 Kd of 2.173 nM.S1PR5-IN-1 binds to S1PR5 and inhibits natural killer cell migration toward sphingosine-1-phosphate.S1PR5-IN-1 can be used for the research of multiple sclerosis .
    S1PR5-IN-1
  • HY-15606
    Tanaproget
    1 Publications Verification

    NSP-989

    Progesterone Receptor Endocrinology
    Tanaproget is an orally effective, selective nonsteroidal progesterone receptor (PR) agonist targeting human PR with an IC50 of 1.7 nM. Tanaproget promotes the interaction between PR receptors and coactivators (such as SRC-1), thereby inhibiting the secretion of matrix metalloproteinases (MMP-3/MMP-7) and reducing endometrial tissue invasion and angiogenesis. Tanaproget can be used for contraception and endometriosis inhibition research .
    Tanaproget
  • HY-155414

    Elastase Ser/Thr Protease Sirtuin Inflammation/Immunology
    Neutrophil elastase inhibitor 5 is an inhibitor of human neutrophil elastase (HNE), proteinase 3 (PR3) and sirt2, with IC50 values of 4.91, 20.69 and 2.42 μM, respectively. Neutrophil elastase inhibitor 5 inhibits superoxide anion production and elastase release in human neutrophils. Neutrophil elastase inhibitor 5 can be used for the research of neutrophil inflammatory diseases .
    Neutrophil elastase inhibitor 5
  • HY-P990827

    TROP2 Cancer
    Anti-TROP-2 Antibody (Pr1E11) is a kind of mouse IgG1 κ chimeric antibody inhibitor, targeting to human TROP-2. Anti-TROP-2 Antibody (Pr1E11) specifically binds to TROP-2 with high affinity and shows low internalization activitv. Anti-TROP-2 Antibody (Pr1E11) can be used for the research of cancer, such as epithelial cancer and primary pancreatic cancer .
    Anti-TROP-2 Antibody (Pr1E11)
  • HY-RS12391

    Small Interfering RNA (siRNA) LPL Receptor Others

    S1PR1 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    S1PR1 Human Pre-designed siRNA Set A
    S1PR1 Human Pre-designed siRNA Set A
  • HY-10964R

    DMXAA (Standard); ASA-404 (Standard)

    STING IFNAR Influenza Virus Reference Standards Infection Cancer
    Vadimezan (Standard) (DMXAA (Standard)) is the analytical standard of Vadimezan (HY-10964). This product is intended for research and analytical applications. Vadimezan (DMXAA; ASA-404), the tumor vascular disrupting agent (tumor-VDA), is a murine agonist of the stimulator of interferon genes (STING) and also a potent inducer of type I IFNs and other cytokines. Vadimezan is unable to activate human STING. Vadimezan has anti-influenza virus H1N1-PR8 activities.
    Vadimezan (Standard)
  • HY-163411

    Elastase Ser/Thr Protease Inflammation/Immunology
    Neutrophil elastase inhibitor 6 is a dual inhibitor of human neutrophil elastase (HNE) and proteinase 3 (PR3), with high selectivity for cathepsin G. Neutrophil elastase inhibitor 6 can be used in the research of chronic neutrophilic inflammatory diseases .
    Neutrophil elastase inhibitor 6
  • HY-RS12394

    Small Interfering RNA (siRNA) LPL Receptor Others

    S1PR2 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    S1PR2 Human Pre-designed siRNA Set A
    S1PR2 Human Pre-designed siRNA Set A
  • HY-106827

    RU 27987

    Progesterone Receptor Androgen Receptor Phosphatase Metabolic Disease
    Trimegestone (RU 27987) is an orally active, selective progestogen and PR ligand, with an IC50 of 7.6 nM for hPR, 4.4 nM for rabbit PR, and 3.3 nM for rat PR. Trimegestone induces Alkaline phosphatase activity. Trimegestone exhibits antiandrogenic activity (IC50 = 303 nM). Trimegestone can be used in research related to menopausal symptoms and osteoporosis .
    Trimegestone
  • HY-P5550

    Influenza Virus Infection
    Urumin has antiviral activity against the human influenza A virus. Urumin inhibits the growth of PR8 influenza virus (IC50: 3.8 μM). Urumin targets the conserved stalk of H1 hemagglutini, and is effective at neutralizing drug-resistant H1 influenza viruses. Urumin protects naive mice from lethal influenza infection .
    Urumin
  • HY-123163

    RWJ-66826; RTI-6617-003

    Progesterone Receptor Glucocorticoid Receptor Androgen Receptor Estrogen Receptor/ERR Endocrinology Cancer
    JNJ-1250132 (RWJ-66826) is an orally active and potent steroidal progesterone receptor (PR) antagonist, with an IC50 of 1.3 nM. JNJ-1250132 inhibits binding of the receptor to DNA in vitro. JNJ-1250132 is a potent competitive inhibitor of binding to the human glucocorticoid receptor (GR) (IC50=0.50 nM) and the rat androgen receptor (AR) (IC50=5.6 nM), and was a weak inhibitor of binding to human Estrogen receptor (ER) (IC50 >3000 nM) .
    JNJ-1250132
  • HY-RS07937

    Small Interfering RNA (siRNA) Others

    M6PR Human Pre-designed siRNA Set A contains three designed siRNAs for M6PR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    M6PR Human Pre-designed siRNA Set A
    M6PR Human Pre-designed siRNA Set A
  • HY-RS12403

    Small Interfering RNA (siRNA) LPL Receptor Others

    S1PR5 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    S1PR5 Human Pre-designed siRNA Set A
    S1PR5 Human Pre-designed siRNA Set A
  • HY-RS12397

    Small Interfering RNA (siRNA) LPL Receptor Others

    S1PR3 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    S1PR3 Human Pre-designed siRNA Set A
    S1PR3 Human Pre-designed siRNA Set A
  • HY-RS12400

    Small Interfering RNA (siRNA) LPL Receptor Others

    S1PR4 Human Pre-designed siRNA Set A contains three designed siRNAs for S1PR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    S1PR4 Human Pre-designed siRNA Set A
    S1PR4 Human Pre-designed siRNA Set A
  • HY-113889

    Progesterone Receptor Cancer
    ZK112993 is a potent progesterone receptor (PR) antagonist. ZK112993 significantly inhibits the growth of T61 human tumors in nude mice .
    ZK112993
  • HY-170819

    SARS-CoV Cathepsin Infection
    VK13 (Compound 6) is a potent inhibitor of human cathepsin L (hCatL) with a Ki value of 0.55 nM and SARS-CoV-2 3CL pro (3CL-PR) with a Ki value of 2.6 nM. VK13 exhibits anti-CoV-2 activity with an EC50 of 1.25 μM .
    VK13
  • HY-P5415

    HIV Others
    DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS is a biological active peptide. (DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS is also called HIV protease substrate I in some literature. It is widely used for the continuous assay for HIV protease activity. The 11-Kd protease (PR) encoded by the human immunodeficiency virus 1 (HIV-1) is essential for the correct processing of viral polyproteins and the maturation of infectious virus, and is therefore a target for the design of selective acquired immunodeficiency syndrome (AIDS) therapeutics. The FRET-based fluorogenic substrate is derived from a natural processing site for HIV-1 PR. Incubation of recombinant HIV-1 PR with the fluorogenic substrate resulted in specific cleavage at the Tyr-Pro bond and a time-dependent increase in fluorescence intensity that is linearly related to the extent of substrate hydrolysis. The fluorescence quantum yields of the HIV-1 PR substrate in the FRET assay increased by 40.0- and 34.4-fold, respectively, per mole of substrate cleaved. Because of its simplicity and precision in the determination of reaction rates required for kinetic analysis, this substrate offers many advantages over the commonly used HPLC or electrophoresis-based assays for peptide substrate hydrolysis by retroviral PRs. Abs/Em = 340nm/490nm.)
    DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS
  • HY-RS05195

    Small Interfering RNA (siRNA) Others

    G6PR Human Pre-designed siRNA Set A contains three designed siRNAs for G6PR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    G6PR Human Pre-designed siRNA Set A
    G6PR Human Pre-designed siRNA Set A
  • HY-P992444

    TNF Receptor Cancer
    PR200 is an anti-Human TNFSF15/TL1A antibody.
    PR200
  • HY-182626

    LPL Receptor Others Neurological Disease Inflammation/Immunology
    CS1P1 is a brain-penetrant and selective S1PR1 antagonist and PET radiotracer, with human S1PR1 IC50 values of 2.1 nM. CS1P1 binds specifically to S1PR1 to enable in vivo receptor expression quantification. CS1P1 can be used as PET radiotracer when labelled with 11C. CS1P1 can be used for the research of multiple sclerosis, neointimal hyperplasia, vascular inflammation .
    CS1P1
  • HY-182618

    LPL Receptor Others
    XAX-162 is a highly selective sphingosine 1-phosphate receptor 2 (S1PR2) agonist with a human EC50 of 0.55 μM. XAX-162 does not activate other S1P receptors. XAX-162 exhibits noncompetitive inhibition of activity by S1PR2 antagonist JTE-013 (HY-100675) .
    XAX-162
  • HY-P992034

    PR001

    Interleukin Related Inflammation/Immunology
    APG808 (PR001) is an anti-human IL-4Rα monoclonal antibody. APG808 binds to IL-4Rα, prevents IL-13Rα1/IL-4Rα heterodimer formation, and disrupts IL-13 and IL-4 mediated signaling. APG808 ablates Fc and complement effector functions. APG808 can be used for the research of chronic obstructive pulmonary disease, asthma, atopic dermatitis .
    APG808

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: